Welcome to Blood Cancer Journal

A peer-reviewed online open access journal seeking to publish articles of the highest quality related to hematologic malignancies and related disorders

Announcements

  • algorithm image

    Blood Cancer Journal proudly publishes ‘Current Treatment Algorithms’, an article type dedicated to providing clear, authoritative, concise treatment pathways for hematologic malignancies.

  • Join Nature Cancer's Chief Editor, Alexia-Ileana Zaromytidou, alongside Prof Adrian Harris, Drs Jan-Paul Medema, Haidong Dong, and Yi-Long Wu, for the first in a new series of Springer Nature webinars that will bring together international experts to discuss ongoing developments in cancer research.

    Thursday 24 June 2021, 8-9.30 am (EDT), 2-3.30 pm (CET), 8-9.30 pm (CST)

  • A sincere thank you to all of the reviewers listed here, who took the time to review for Blood Cancer Journal in 2020. The journal could not exist without the knowledge and critical evaluation provided by our reviewers - content is often vastly improved by the suggestions and recommendations they provide.

  • BCJ Twitter Logo

    Join the Blood Cancer Journal Twitter Community

  • @BloodCancerJnl
  • Follow us to keep up-to-date with the latest research and news from Blood Cancer Journal. Share your views, retweet and give us feedback.

Advertisement

Current Treatment Algorithms

Current Treatment Algorithms

A new year brings a new series for Blood Cancer Journal - January 2018 sees the launch of a new article type called ‘Current Treatment Algorithms’, a new series dedicated to providing clear, authoritative, concise treatment pathways for hematologic malignancies.
Collection